Showing 1121-1130 of 2908 results for "".
Blood-Based Biomarkers in Alzheimer Disease: Clinical Implementation and Limitations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/blood-based-biomarkers-in-alzheimer-disease-clinical-implementation-and-limitations/32100/Although biomarkers for Alzheimer disease have the potential to improve evaluation and care, barriers to implementation remain.Understanding Disparities Associated with Alzheimer Disease and Related Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/understanding-disparities-associated-with-alzheimer-disease-and-related-dementias/32142/Clinicians need to take into consideration a variety of factors resulting in disparities in health outcomes in people with dementia, including socioeconomic status, race, ethnicity, environment, life experiences, and culture.Wandering & Sundowning in Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/wandering-sundowning-in-dementia/31912/Preventive and acute management of some of the most challenging aspects of dementia is possible.Myasthenia Gravis: Making Progress for More Accurate Diagnoses and Targeted Treatments
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis-making-progress-for-more-accurate-diagnoses-and-targeted-treatments/32114/Advances in testing and treatments for myasthenia gravis are leading to more accurate diagnoses and improvements in symptom control for individuals with this rare chronic autoimmune disease.Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.Relapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapse-management-in-multiple-sclerosis-corticosteroids-remain-the-linchpin-of-therapies/32084/Several modalities are available for the treatment of multiple sclerosis relapse, including corticosteroids, intravenous immunoglobulins, and therapeutic apheresis.Restorative and Rehabilitative Treatments for Stroke in the Outpatient Setting
https://practicalneurology.com/diseases-diagnoses/stroke/restorative-and-rehabilitative-treatments-for-stroke-in-the-outpatient-setting/31962/Rehabilitation and recovery after stroke are a lifelong process best achieved through coordinated outpatient care following the acute period of recovery.Posttraumatic Headache: A Comprehensive Approach
https://practicalneurology.com/diseases-diagnoses/headache-pain/posttraumatic-headache-a-comprehensive-approach/32130/A multimodal, comprehensive, individualized approach to the treatment of posttraumatic headache is essential to optimize outcomes.Considerations for the Management of Optic Neuritis in the Inpatient Setting
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/considerations-for-the-management-of-optic-neuritis-in-the-inpatient-setting/31976/Optic neuritis is not only a potential presenting symptom of multiple sclerosis but of other demyelinating and autoimmune diseases.Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.